UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Impact of care fragmentation in patients receiving neoadjuvant chemotherapy and radical cystectomy for bladder cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.468-468

2022

Link zum Volltext

Verfügbarkeit prüfen

PD09-04 CHARACTERIZATION OF SIGNIFICANT GENETIC DRIVERS IN METASTATIC PROSTATE CANCER TROPISM

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Link zum Volltext

Verfügbarkeit prüfen

MP05-13 TESTOSTERONE DECREASES PROGRAMMED DEATH LIGAND-1 (PDL-1) LEVEL IN PROSTATE CANCER

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Link zum Volltext

Verfügbarkeit prüfen

3JC48-3: Novel MYC inhibition in advanced prostate cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.181-181

2022

Link zum Volltext

Verfügbarkeit prüfen

E-Cadherin Facilitates Protein Kinase D1 Activation and Subcellular Localization

Journal of cellular physiology, 2016-12, Vol.231 (12), p.2741-2748

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-243: Protein kinase D1 induces cell cycle arrest independent from check point kinases

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-243-LB-243

2018

Link zum Volltext

Verfügbarkeit prüfen

INCREASING INCIDENCE OF ALL STAGES OF KIDNEY CANCER IN THE LAST 2 DECADES IN THE UNITED STATES: AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM DATA

The Journal of urology, 2002, Vol.167 (1), p.57-60

2002

Link zum Volltext

Verfügbarkeit prüfen

Robotic urological surgery in patients with prior abdominal operations is not associated with increased complications

International journal of urology, 2006-03, Vol.13 (3), p.248-251

2006

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells

Nanomedicine (London, England), 2016-05, Vol.11 (10), p.1207-1222

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathology grade influences competing mortality risks in elderly men with prostate cancer

Urologic oncology, 2021-08, Vol.39 (8), p.493.e1-493.e7

2021

Link zum Volltext

Verfügbarkeit prüfen

MP32-11 NATURAL HISTORY, AND IMPACT OF SURGERY AND RADIATION ON SURVIVAL OUTCOMES OF MEN DIAGNOSED WITH LOW GRADE PROSTATE CANCER AT ≤55 YEARS OF AGE - A 25-YEAR FOLLOW UP OF >60,000 MEN

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Link zum Volltext

Verfügbarkeit prüfen

MP62-05 IMPACT OF INTRA-DUCTAL CARCINOMA ON CLINICAL OUTCOMES IN MEN WITH PROSTATE CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Link zum Volltext

Verfügbarkeit prüfen

MP14-16 COMBINATION THERAPY FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Link zum Volltext

Verfügbarkeit prüfen

MP83-17 SOCIOECONOMIC FACTORS ASSOCIATED WITH PATIENT NO SHOWS IN THE AMBULATORY UROLOGY CLINIC

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Link zum Volltext

Verfügbarkeit prüfen

Urinary stone disease burden is increased in patients with cognitive impairment

American journal of clinical and experimental urology, 2023-01, Vol.11 (3), p.249-257

2023

Link zum Volltext

Verfügbarkeit prüfen

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer

Urology (Ridgewood, N.J.), 1997-12, Vol.50 (6), p.1007-1015

1997

Link zum Volltext

Verfügbarkeit prüfen

Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate

The Prostate, 2015-06, Vol.75 (9), p.988-1000

2015

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis

Indian journal of urology, 2022-07, Vol.38 (3), p.220-226

2022

Link zum Volltext

Verfügbarkeit prüfen

PD13-03 COMPETING MORTALITY RISKS IN ELDERLY MEN WITH PROSTATE CANCER IN THE UNITED STATES

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Link zum Volltext

Verfügbarkeit prüfen

MP79-06 COMPARATIVE EFFICACY OF ENZALUTAMIDE, APALUTAMIDE AND DAROLUTAMIDE FOR TREATMENT ON NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: A NETWORK META-ANALYSIS

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1625: c-Myc inhibition in prostate cancer cell lines

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1625-1625

2022

Link zum Volltext

Verfügbarkeit prüfen

Cell line modeling to study biomarker panel in prostate cancer

The Prostate, 2016-02, Vol.76 (3), p.245-258

2016

Link zum Volltext

Verfügbarkeit prüfen

Rapid bench to bed in management of metastatic prostate cancer

Indian journal of urology, 2016-10, Vol.32 (4), p.255-256

Balaji, K

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4342: Differential expression of novel PKD1 related biomarker panel in African American men with prostate cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4342-4342

2015

Link zum Volltext

Verfügbarkeit prüfen

The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn2+-chelation and inhibiting the serine protease Omi/HtrA2

The Prostate, 2015-03, Vol.75 (4), p.360-369

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(57)
Tagungsberichte
(2)

Sprache

Englisch
(59)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of care fragmentation in patients receiving neoadjuvant chemotherapy and radical cystectomy for bladder cancer

PD09-04 CHARACTERIZATION OF SIGNIFICANT GENETIC DRIVERS IN METASTATIC PROSTATE CANCER TROPISM

MP05-13 TESTOSTERONE DECREASES PROGRAMMED DEATH LIGAND-1 (PDL-1) LEVEL IN PROSTATE CANCER

3JC48-3: Novel MYC inhibition in advanced prostate cancer

E-Cadherin Facilitates Protein Kinase D1 Activation and Subcellular Localization

Abstract LB-243: Protein kinase D1 induces cell cycle arrest independent from check point kinases

INCREASING INCIDENCE OF ALL STAGES OF KIDNEY CANCER IN THE LAST 2 DECADES IN THE UNITED STATES: AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM DATA

Robotic urological surgery in patients with prior abdominal operations is not associated with increased complications

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells

Pathology grade influences competing mortality risks in elderly men with prostate cancer

MP32-11 NATURAL HISTORY, AND IMPACT OF SURGERY AND RADIATION ON SURVIVAL OUTCOMES OF MEN DIAGNOSED WITH LOW GRADE PROSTATE CANCER AT ≤55 YEARS OF AGE - A 25-YEAR FOLLOW UP OF >60,000 MEN

MP62-05 IMPACT OF INTRA-DUCTAL CARCINOMA ON CLINICAL OUTCOMES IN MEN WITH PROSTATE CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS

MP14-16 COMBINATION THERAPY FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

MP83-17 SOCIOECONOMIC FACTORS ASSOCIATED WITH PATIENT NO SHOWS IN THE AMBULATORY UROLOGY CLINIC

Urinary stone disease burden is increased in patients with cognitive impairment

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer

Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate

Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis

PD13-03 COMPETING MORTALITY RISKS IN ELDERLY MEN WITH PROSTATE CANCER IN THE UNITED STATES

MP79-06 COMPARATIVE EFFICACY OF ENZALUTAMIDE, APALUTAMIDE AND DAROLUTAMIDE FOR TREATMENT ON NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER: A NETWORK META-ANALYSIS

Abstract 1625: c-Myc inhibition in prostate cancer cell lines

Cell line modeling to study biomarker panel in prostate cancer

Rapid bench to bed in management of metastatic prostate cancer

Abstract 4342: Differential expression of novel PKD1 related biomarker panel in African American men with prostate cancer

The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn2+-chelation and inhibiting the serine protease Omi/HtrA2

Suchergebnisse filtern